Why the study?
To evaluate carotid atherosclerotic lesions in patients with metabolic syndrome depending on the presence of type 2 diabetes and assess demographic factors affecting intima-media thickness.
Does the presence of Type 2 Diabetes increase carotid intima-media thickness in patients with metabolic syndrome?
Does the presence of Type 2 Diabetes increase carotid intima-media thickness in patients with metabolic syndrome?
In patients with metabolic syndrome, the presence of type 2 diabetes is associated with significantly increased carotid intima-media thickness, indicating more advanced early atherosclerosis.
Answers are grounded in this paper and cite their sources.
Supports DMt2 association with greater carotid IMT in metabolic syndrome; hypothesis-generating for accelerated atherosclerosis, needs prospective confirmation.
Background: Metabolic syndrome (MetS), increasingly diagnosed among the Polish population, is a combination of factors that are associated with an increased risk of atherosclerosis and cardiovascular diseases. Intima-media thickness (IMT) of the common carotid artery has been suggested as, simply, a non-invasive and reproducible marker of the early stages of the atherosclerotic process. The carotid IMT can also be a strong predictor of future cerebral and cardiovascular events. The aim of our study was to evaluate atherosclerotic lesions in carotid vessels in patients with MetS depending on the presence of DMt2 and to assess which demographic factors affect the level of IMT. The study involved 335 subjects diagnosed with MetS, including 211 females (65%) and 124 males (37%) aged 37–82. The diagnosis of MetS was made on the basis of the International Diabetes Federation (IDF) criteria. The patients were divided into two subgroups: with DMt2 and without DMt2. The value of IMT depended on gender, education, and smoking status. We noticed that patients with DMt2 had the highest measurement of IMT compared with other groups (1.01 vs. 0.98). Additionally, a statistically significant difference between the subgroup with DMt2 and those without DMt2 was found (1.01 vs. 0.92; p < 0.005). Ultrasound assessment of the carotid IMT should be used more often in the diagnosis and monitoring of high cardiovascular risk and early progression of atherosclerosis, especially in patients with MetS with current DMt2.
No takes yet. Share an insight, caveat, or question.
Gierach et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: